PL1853220T5 - Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne - Google Patents

Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne

Info

Publication number
PL1853220T5
PL1853220T5 PL06709907.7T PL06709907T PL1853220T5 PL 1853220 T5 PL1853220 T5 PL 1853220T5 PL 06709907 T PL06709907 T PL 06709907T PL 1853220 T5 PL1853220 T5 PL 1853220T5
Authority
PL
Poland
Prior art keywords
nsaid
compositions
preparation
medical use
containing lozenges
Prior art date
Application number
PL06709907.7T
Other languages
English (en)
Other versions
PL1853220T3 (pl
Inventor
Kirsty Sawicka
Jasmine Takhar
Paul Marshall
Michael Fanfarillo
Original Assignee
Reckitt Benckiser Healthcare (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1853220(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare (Uk) Limited filed Critical Reckitt Benckiser Healthcare (Uk) Limited
Publication of PL1853220T3 publication Critical patent/PL1853220T3/pl
Publication of PL1853220T5 publication Critical patent/PL1853220T5/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06709907.7T 2005-03-01 2006-02-27 Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne PL1853220T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504157A GB2423710A (en) 2005-03-01 2005-03-01 Lozenge production process
EP06709907.7A EP1853220B2 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use
PCT/GB2006/000680 WO2006092569A1 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use

Publications (2)

Publication Number Publication Date
PL1853220T3 PL1853220T3 (pl) 2018-01-31
PL1853220T5 true PL1853220T5 (pl) 2023-08-07

Family

ID=34430399

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17185774T PL3284458T3 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek do ssania zawierających NLPZ
PL06709907.7T PL1853220T5 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17185774T PL3284458T3 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek do ssania zawierających NLPZ

Country Status (21)

Country Link
US (2) US10328039B2 (pl)
EP (3) EP3284458B1 (pl)
JP (1) JP2008531664A (pl)
KR (2) KR20140011422A (pl)
CN (2) CN101132762A (pl)
AU (1) AU2006219777B2 (pl)
CA (1) CA2599861A1 (pl)
DK (1) DK1853220T3 (pl)
ES (2) ES2886323T3 (pl)
GB (1) GB2423710A (pl)
HU (1) HUE034872T2 (pl)
MX (1) MX2007009275A (pl)
MY (1) MY154770A (pl)
PL (2) PL3284458T3 (pl)
PT (1) PT1853220T (pl)
RU (1) RU2403032C2 (pl)
SG (1) SG161201A1 (pl)
SI (2) SI3284458T1 (pl)
TW (1) TWI372065B (pl)
WO (1) WO2006092569A1 (pl)
ZA (1) ZA200706067B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids
GB201215988D0 (en) * 2012-09-07 2012-10-24 Reckitt Benckiser Healthcare Int Ltd Pharmaceutical compositions comprising flurbiprofen
US9914968B2 (en) 2012-09-26 2018-03-13 Cepheid Honeycomb tube
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
MX2022002169A (es) * 2019-08-22 2022-03-22 Applied Biological Laboratories Inc Composiciones y metodos que utilizan farmacos antiinflamatorios no esteroideos.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084864A (en) 1964-02-06 1967-09-27 Merck & Co Inc Medicated lozenges
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
DE60120710T2 (de) * 2000-08-18 2007-06-14 Pharmacia Corp. Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
US6689382B2 (en) 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
US20070190153A1 (en) 2004-03-05 2007-08-16 Jonathan Farber Delivery systems for non-steroidal anti-inflammatory drugs (nsaids)

Also Published As

Publication number Publication date
JP2008531664A (ja) 2008-08-14
KR20140011422A (ko) 2014-01-28
ES2886323T3 (es) 2021-12-17
ES2647488T4 (es) 2024-01-16
HUE034872T2 (hu) 2018-03-28
CA2599861A1 (en) 2006-09-08
ES2647488T5 (es) 2023-08-09
RU2007136106A (ru) 2009-04-10
SG161201A1 (en) 2010-05-27
PT1853220T (pt) 2017-11-17
KR20070110053A (ko) 2007-11-15
SI1853220T1 (sl) 2017-12-29
WO2006092569A1 (en) 2006-09-08
GB2423710A (en) 2006-09-06
PL3284458T3 (pl) 2021-12-13
DK1853220T3 (da) 2017-11-13
EP2210587A1 (en) 2010-07-28
TW200716199A (en) 2007-05-01
RU2403032C2 (ru) 2010-11-10
EP1853220B1 (en) 2017-08-16
CN101132762A (zh) 2008-02-27
CN103156818A (zh) 2013-06-19
ZA200706067B (en) 2008-09-25
US10328039B2 (en) 2019-06-25
US20190307711A1 (en) 2019-10-10
US20080206326A1 (en) 2008-08-28
AU2006219777A1 (en) 2006-09-08
MY154770A (en) 2015-07-15
US10933040B2 (en) 2021-03-02
SI3284458T1 (sl) 2021-11-30
AU2006219777B2 (en) 2010-07-01
EP1853220A1 (en) 2007-11-14
EP3284458A1 (en) 2018-02-21
SI1853220T2 (sl) 2023-07-31
EP1853220B2 (en) 2023-03-29
TWI372065B (en) 2012-09-11
PL1853220T3 (pl) 2018-01-31
KR101358687B1 (ko) 2014-02-07
MX2007009275A (es) 2007-09-19
ES2647488T3 (es) 2017-12-21
EP3284458B1 (en) 2021-06-16
GB0504157D0 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
HUS2200002I1 (hu) Immunogén készítmény
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
PT1928223E (pt) Singularizador de sementes
ITMI20052486A1 (it) Procedimento di sintesi di intermedi per la preparazione di astaxantina
PT1850664E (pt) Formulação de cápsulas
EP1863899A4 (en) COMPOSITIONS FOR TREATING SKIN
DE602006003922D1 (de) Chirurgisches Implantat
NO20055643D0 (no) Preparation of lodixanol
EP1906944A4 (en) SKI ANDRIN-B-PREPARATION
NO20082458L (no) Fremgangsmåter for fremstilling av cyklopropyl-amidderivat
DK2182007T3 (da) Fremgangsmåde til fremstilling af humant G-CSF
PL1853220T5 (pl) Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne
ITMI20051989A1 (it) Procedimerntyo per la preparazione di composti antagonisti di angiotensina ii
ITMI20061848A1 (it) Procedimento per la preparazione di composti feniltetrazolici
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1938292T3 (da) Faremeldeanlæg
ITMI20051971A1 (it) Procedimento per la preparazione di - modafinil
ITMI20052464A1 (it) Procedimento per la preparazi9one di norelgestromin norelgestromina
ITMI20060489A1 (it) Procedimento per la preparazione di 1-beono-3-trifluorometossibenzene
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
ITMI20062515A1 (it) Procedimento per la preparazione di 3,6-di-o-aceti-d-glicali